Occurrence and removal of psychiatric pharmaceuticals in the Tehran South Municipal Wastewater Treatment Plant.


Journal

Environmental science and pollution research international
ISSN: 1614-7499
Titre abrégé: Environ Sci Pollut Res Int
Pays: Germany
ID NLM: 9441769

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 10 02 2022
accepted: 12 10 2022
pubmed: 15 11 2022
medline: 11 3 2023
entrez: 14 11 2022
Statut: ppublish

Résumé

Psychiatric drugs released by humans in wastewater have received more attention because of their potential risks for aquatic organisms. In this study, the occurrence of the two most common groups of psychiatric drugs (sedatives-hypnotics-anxiolytics and antidepressants) were evaluated in the Tehran South Municipal Wastewater Treatment Plant. All the target sedatives-hypnotics-anxiolytics (alprazolam, phenobarbital, and thioridazine) and antidepressants (fluoxetine, citalopram, sertraline, and venlafaxine) were observed in influent and secondary clarification (SC) effluent. Thioridazine (164.25 ± 218.74 ng/L) and citalopram (672.53 ± 938.56 ng/L) had the highest mean concentrations in the influent, while alprazolam (5.09 ± 2.33 ng/L) and citalopram (776.97 ± 1088.01 ng/L) had the highest concentrations in the SC effluent. The higher concentrations of the psychiatric drugs, except thioridazine, were detected in the SC effluent compared to the concentrations in the influent. The increased drugs concentrations, with negative removal efficiencies, were more distinctive in the cold season samples. Psychiatric drugs processed in the chlorination unit followed a completely different pattern compared to the drugs in the biological treatment unit. All the drugs' concentrations, except thioridazine, decreased in the chlorination unit, ranging between 27 ± 14% for alprazolam and 75 ± 10% for citalopram. However, the mean concentrations of the detected drugs were as follows: sertraline (11.96 ± 11.62 ng/L) and venlafaxine (184.94 ± 219.74 ng/L) which could cause environmental and ecological concerns.

Identifiants

pubmed: 36374381
doi: 10.1007/s11356-022-23667-5
pii: 10.1007/s11356-022-23667-5
pmc: PMC9660169
doi:

Substances chimiques

Water Pollutants, Chemical 0
Citalopram 0DHU5B8D6V
Sertraline QUC7NX6WMB
Venlafaxine Hydrochloride 7D7RX5A8MO
Thioridazine N3D6TG58NI
Anti-Anxiety Agents 0
Alprazolam YU55MQ3IZY
Antidepressive Agents 0
Pharmaceutical Preparations 0
Hypnotics and Sedatives 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

27041-27055

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Chemosphere. 2014 Sep;111:418-26
pubmed: 24997947
Chemosphere. 2012 Apr;87(5):453-62
pubmed: 22221664
Chemosphere. 2012 Sep;89(2):129-35
pubmed: 22704974
Water Res. 2017 Jan 1;108:57-67
pubmed: 27825683
Environ Pollut. 2015 Jan;196:247-56
pubmed: 25463720
Environ Pollut. 2016 Jun;213:658-670
pubmed: 27020046
PLoS One. 2013;8(1):e55053
pubmed: 23383055
Chemosphere. 2015 Nov;138:486-93
pubmed: 26188705
Water Res. 2012 Nov 15;46(18):6013-22
pubmed: 22967903
Chemosphere. 2013 Mar;90(10):2520-5
pubmed: 23228908
J Chromatogr A. 2006 May 19;1115(1-2):187-95
pubmed: 16574138
Molecules. 2020 Feb 25;25(5):
pubmed: 32106570
Chemosphere. 2009 Nov;77(10):1257-74
pubmed: 19815251
J Epidemiol Glob Health. 2018 Dec;8(3-4):213-219
pubmed: 30864766
Chemosphere. 2019 Jul;226:565-575
pubmed: 30953901
Environ Toxicol Chem. 2009 Dec;28(12):2522-7
pubmed: 19449981
Sci Total Environ. 2017 Apr 1;583:36-52
pubmed: 28126283
Molecules. 2014 Jan 20;19(1):1212-22
pubmed: 24448062
J Sep Sci. 2013 Feb;36(3):564-71
pubmed: 23303742
Sci Total Environ. 2013 Sep 1;461-462:302-16
pubmed: 23732224
Environ Sci Pollut Res Int. 2012 Mar;19(3):689-99
pubmed: 21909967
Environ Toxicol Chem. 2003 Dec;22(12):2881-9
pubmed: 14713027
Environ Res. 2020 Dec;191:110152
pubmed: 32877707
J Chromatogr A. 2021 Aug 30;1652:462369
pubmed: 34246959
Environ Sci Technol. 2006 Dec 1;40(23):7200-6
pubmed: 17180967
Sci Total Environ. 2012 Jul 1;429:123-55
pubmed: 22583809
Chemosphere. 2008 Nov;73(9):1379-86
pubmed: 18849059
Environ Sci Pollut Res Int. 2021 Nov;28(42):59745-59770
pubmed: 34146330
Anal Chem. 2005 Oct 1;77(19):389A-394A
pubmed: 16247935
Chemosphere. 2017 Jan;167:429-437
pubmed: 27750166
Chemosphere. 2011 Apr;83(4):564-71
pubmed: 21211816
Environ Sci Technol. 2008 Jul 1;42(13):4811-7
pubmed: 18678010
Water Res. 2013 Nov 1;47(17):6475-87
pubmed: 24091184
Chemosphere. 2021 Aug;276:130147
pubmed: 33714880
Sci Total Environ. 2012 Oct 15;437:185-95
pubmed: 22940043
Water Res. 2012 Nov 1;46(17):5600-5612
pubmed: 22898669
Water Res. 2005 Sep;39(15):3607-17
pubmed: 16061268
Sci Total Environ. 2015 May 1;514:273-80
pubmed: 25666287
Environ Toxicol Chem. 2010 Jan;29(1):79-89
pubmed: 20821422

Auteurs

Somayeh Golbaz (S)

Department of Environmental Health Engineering, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Mirzaman Zamanzadeh (M)

inCTRL Solutions Inc, 7 Innovation Dr., Suite 107, Dundas, ON, Canada.

Kamyar Yaghmaeian (K)

Department of Environmental Health Engineering, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. K-yaghmaeian@sina.tums.ac.ir.
Center for Solid Waste Management (CSWM), Institute for Environmental Research (IER), Tehran University of Medical Sciences, Tehran, Iran. K-yaghmaeian@sina.tums.ac.ir.

Ramin Nabizadeh (R)

Department of Environmental Health Engineering, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Nushin Rastkari (N)

Department of Environmental Health Engineering, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Hadi Esfahani (H)

Chemistry and Chemical Engineering Research Center of Iran, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH